Cargando…
PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429407/ http://dx.doi.org/10.1097/01.HS9.0000975148.14988.0d |
| _version_ | 1785090705306157056 |
|---|---|
| author | Girnius, Saulius K. Richter, Joshua Lyons, Roger M. Bogard, Kimberly Manda, Sudhir Birhiray, Ruemu E. Yimer, Habte A. Tran, Kim Kambhampati, Suman Arora, Jyoti Noga, Stephen Rifkin, Robert |
| author_facet | Girnius, Saulius K. Richter, Joshua Lyons, Roger M. Bogard, Kimberly Manda, Sudhir Birhiray, Ruemu E. Yimer, Habte A. Tran, Kim Kambhampati, Suman Arora, Jyoti Noga, Stephen Rifkin, Robert |
| author_sort | Girnius, Saulius K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429407 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294072023-08-17 PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 Girnius, Saulius K. Richter, Joshua Lyons, Roger M. Bogard, Kimberly Manda, Sudhir Birhiray, Ruemu E. Yimer, Habte A. Tran, Kim Kambhampati, Suman Arora, Jyoti Noga, Stephen Rifkin, Robert Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429407/ http://dx.doi.org/10.1097/01.HS9.0000975148.14988.0d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Girnius, Saulius K. Richter, Joshua Lyons, Roger M. Bogard, Kimberly Manda, Sudhir Birhiray, Ruemu E. Yimer, Habte A. Tran, Kim Kambhampati, Suman Arora, Jyoti Noga, Stephen Rifkin, Robert PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title | PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title_full | PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title_fullStr | PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title_full_unstemmed | PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title_short | PB2089: IN-CLASS TRANSITION FROM PARENTERAL BORTEZOMIB TO ORAL IXAZOMIB IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) ACCORDING TO AGE AND FRAILTY STATUS: UPDATED SUBGROUP ANALYSIS OF US MM-6 |
| title_sort | pb2089: in-class transition from parenteral bortezomib to oral ixazomib in newly diagnosed multiple myeloma (ndmm) according to age and frailty status: updated subgroup analysis of us mm-6 |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429407/ http://dx.doi.org/10.1097/01.HS9.0000975148.14988.0d |
| work_keys_str_mv | AT girniussauliusk pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT richterjoshua pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT lyonsrogerm pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT bogardkimberly pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT mandasudhir pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT birhirayruemue pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT yimerhabtea pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT trankim pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT kambhampatisuman pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT arorajyoti pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT nogastephen pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 AT rifkinrobert pb2089inclasstransitionfromparenteralbortezomibtooralixazomibinnewlydiagnosedmultiplemyelomandmmaccordingtoageandfrailtystatusupdatedsubgroupanalysisofusmm6 |